HQL
$14.08
abrdn Life Sciences Investors
Fund Family: abrdn Life Sciences Investors
Explore sections
Top 10 Holdings
Largest positions representing 42.7% of the portfolio
42.7%
of portfolio
Loading chart...
- Regeneron Pharmaceuticals IncManufacturing7.35%
- Amgen IncManufacturing7.28%
- Gilead Sciences IncManufacturing6.61%
- Vertex Pharmaceuticals IncManufacturing4.53%
- Alnylam Pharmaceuticals IncManufacturing3.45%
- BioMarin Pharmaceutical IncManufacturing3.44%
- State Street Institutional US Government Money Market FundUnknown2.92%
- Insmed IncUnknown2.42%
- ARGENX SEManufacturing2.41%
- BioNTech SEManufacturing2.34%
| Rank | Company | Ticker | Sector | Weight (%) |
|---|---|---|---|---|
1 | Regeneron Pharmaceuticals Inc 75886F107 | REGN | Manufacturing | 7.35% |
2 | Amgen Inc 031162100 | AMGN | Manufacturing | 7.28% |
3 | Gilead Sciences Inc 375558103 | GILD | Manufacturing | 6.61% |
4 | Vertex Pharmaceuticals Inc 92532F100 | VRTX | Manufacturing | 4.53% |
5 | Alnylam Pharmaceuticals Inc 02043Q107 | ALNY | Manufacturing | 3.45% |
6 | BioMarin Pharmaceutical Inc 09061G101 | BMRN | Manufacturing | 3.44% |
7 | State Street Institutional US Government Money Market Fund 857492706 | GVMXX | Unknown | 2.92% |
8 | Insmed Inc 457669307 | IM8N | Unknown | 2.42% |
9 | ARGENX SE 04016X101 | ARGX | Manufacturing | 2.41% |
10 | BioNTech SE 09075V102 | BNTX | Manufacturing | 2.34% |